Denied health claims on weight loss and normal gingival function
European Union
May 10, 2022
Commission Regulation (EU) 2022/711 of 6 May 2022 refusing to authorise certain health claims made on foods, other than those referring to the reduction of disease risk and to children’s development and health.
Rejected health claims
Application – Relevant provisions of Regulation (EC) No 1924/2006 |
Nutrient, substance, food or food category |
Claim |
EFSA opinion reference |
Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data |
GlycoLiteTM – A proprietary standardised aqueous extract from white kidney bean (Phaseolus vulgaris L.) |
GlycoLite™ helps to reduce body weight |
Q-2018-00611 |
Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data |
Lozenges with two Lactobacillus reuteri strains: Lactobacillus reuteri DSM 17938 and Lactobacillus reuteri ATCC PTA 5289, approximately equal amount of each strain (total minimum amount of 1 × 108 CFU/lozenge of each bacterial strain) |
Lozenges containing Lactobacillus reuteri DSM 17938 and Lactobacillus reuteri ATCC PTA 5289 support normal gum function |
Q-2019-00383 |
For further information (in English), click on the Link